Diagnosed with NF2-Related schwannomatosis
Children's Tumor Foundation | 2024
Visit WebsiteChildren's Tumor Foundation | 2024
Visit WebsiteChildren's Tumor Foundation | 2021
Visit WebsiteChildren's Tumor Foundation
Visit WebsiteChildren's Tumor Foundation | 2024
Visit Website
Recursion Pharmaceuticals Inc.
This is a parallel-group, two-staged, Phase 2/3, randomized, multi-center study to investigate the efficacy and safety of REC-2282 in patients…
View Article
NIH/National Cancer Institute
| 2026
By Dr. Staci Martin Peron
Remote research study developed by Dr. Staci Martin Peron at the National Cancer Institute in Bethesda, MD. The study is…
View Article
2024 NF Midwest iNFo Fair
| 2024
By Miranda McManus, MS
Children's Tumor Foundation | 2023
Visit WebsiteChildren's Tumor Foundation | 2024
Visit Website
MedlinePlus.gov
| 2021
By National Institutes of Health
© 2026 Neurofibromatosis Midwest - non profit 501(c)(t3). Site Map - Privacy Policy
The resources on this site should not be used as a substitute for professional medical care or advice on Neurofibromatosis. Users seeking information about a personal genetic disease, syndrome, or condition should consult with a qualified healthcare professional.